4Viswanatha D,Foucar K.Hodgkin and non-Hodgkin lymphoma involving bone marrow [J].Semin Diagn Pathol,2003,20(3):196-210.
5Crotty PL,Smith BR,Tallini G.Morphologic,immunophenotypic,and molecular evaluation of bone marrow involvement in non-Hodgkin's lymphoma [J].Diagn Mol Pathol,1998,7(2):90-95.
6Campbell JK,Matthews JP,Seymour JF,et al.Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma [J].Ann Oncol,2003,14(2):273-276.
7Cheson BD,Horning SJ,Coiffier B,et al.Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas.NCI Sponsored International Working Group [J].J Clin Oncol,1999,17(4):1244-1253.
8Stetler-Stevenson M,Braylan RC.Flow cytometric analysis of lymphomas and lymphoproliferative disorders [J].Semin Hematol,2001,38(2):111-123.
9Li S,Eshleman JR,Borowitz MJ.Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma [J].Am J Clin Pathol,2002,118(2):229-234.
10Hanson CA,Kurtin PJ,Katzmann JA,et al.Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma [J].Blood,1999,94(11):3889-3896.
